Skip to main content
Top
Published in: Radiation Oncology 1/2019

Open Access 01-12-2019 | Bronchoscopy | Research

Improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB)

Authors: Hayley Stowe, Stella Ogake, Sunil Sharma, Suzanne Kelly, Morgan McDonald, Kayla Stanley, Paul Walker, Hyder Arastu, Carlos Anciano Granadillo, Mark Bowling, Andrew Ju

Published in: Radiation Oncology | Issue 1/2019

Login to get access

Abstract

Background

Stereotactic ablative radiotherapy (SABR) is a treatment option for patients with early stage non-small cell lung cancer (NSCLC) and recurrent or oligometastatic disease who are not surgical candidates. Due to the continuous motion of tumors within the lungs, implementing a strategy to track the target lesion is crucial. One method is to place fiducial markers which the robotic SABR system is able to track during treatment. However, placing these markers in a manner that maximizes tracking efficacy can be challenging. Using a novel fiducial placement guidance system (FPGS) during fiducial deployment may offer a way to improve the quantity of fiducials tracked by the robotic SABR system.

Method

This was an institutional, retrospective review identifying all patients who received robotic SABR for lung tumors from May 2015 until January 2017. The FPGS was instituted in May 2016. The median number of fiducials tracked and the rate of complication was compared between patients whose fiducials were placed using FPGS versus those that were not.

Results

A total of 128 patients with 147 treated lung lesions were identified. Of the lesions that utilized FPGS (n = 44), 28 had 2 tracked fiducials (63.6%), 14 had 3 (31.8%) and 2 had 4 (4.6%). Of the lesions treated without FPGS (n = 103), 5 had 1 tracked fiducial (4.9%), 91 had 2 (88.4%), 6 had 3 (5.8%), and 2 had 4 (1.9%). A significant improvement in the median number of fiducials tracked per fraction was observed for the lesions with fiducials placed using FPGS on Wilcoxon rank sum test (p < 0.001). The rate of complication was low and not statistically different between cohorts (p = 0.44).

Conclusions

The FPGS can be used during the deployment of fiducial markers and may increase the number of fiducials tracked.

Trial registration

An exemption for this retrospective review was granted by the East Carolina University IRB under UMCIRB 15-001726.
Literature
1.
go back to reference Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: history and updated role. Lung Cancer. 2015;90(3):388–96.CrossRef Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: history and updated role. Lung Cancer. 2015;90(3):388–96.CrossRef
2.
go back to reference Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev. 1989;16(4):247–55.CrossRef Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev. 1989;16(4):247–55.CrossRef
3.
go back to reference Dosoretz DE, et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol. 1996;6:2 Elsevier.CrossRef Dosoretz DE, et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol. 1996;6:2 Elsevier.CrossRef
4.
go back to reference Kaskowitz L, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993;27(3):517–23.CrossRef Kaskowitz L, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993;27(3):517–23.CrossRef
5.
go back to reference McGarry RC, et al. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121(4):1155–8.CrossRef McGarry RC, et al. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121(4):1155–8.CrossRef
6.
go back to reference Timmerman R, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.CrossRef Timmerman R, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.CrossRef
7.
go back to reference Low DA, et al. Novel breathing motion model for radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(3):921–9.CrossRef Low DA, et al. Novel breathing motion model for radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(3):921–9.CrossRef
8.
go back to reference Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30(6):637–44.CrossRef Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30(6):637–44.CrossRef
9.
go back to reference Anantham D, et al. Electromagnetic navigation bronchoscopy-guided fiducial placement for robotic stereotactic radiosurgery of lung tumors: a feasibility study. Chest. 2007;132(3):930–5.CrossRef Anantham D, et al. Electromagnetic navigation bronchoscopy-guided fiducial placement for robotic stereotactic radiosurgery of lung tumors: a feasibility study. Chest. 2007;132(3):930–5.CrossRef
10.
go back to reference Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol. 2011;43:181–94. Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol. 2011;43:181–94.
11.
go back to reference Murphy MJ. Fiducial-based targeting accuracy for external-beam radiotherapy. Med Phys. 2002;29(3):334–44.CrossRef Murphy MJ. Fiducial-based targeting accuracy for external-beam radiotherapy. Med Phys. 2002;29(3):334–44.CrossRef
12.
go back to reference Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp MM, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg. 2003;75(4):1097–101.CrossRef Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp MM, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg. 2003;75(4):1097–101.CrossRef
13.
go back to reference Schweikard A, et al. Robotic motion compensation for respiratory movement during radiosurgery. Comput Aided Surg. 2000;5(4):263–77.CrossRef Schweikard A, et al. Robotic motion compensation for respiratory movement during radiosurgery. Comput Aided Surg. 2000;5(4):263–77.CrossRef
14.
go back to reference Nuyttens JJ, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: marker placement and early results. Acta Oncol. 2006;45(7):961–5.CrossRef Nuyttens JJ, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: marker placement and early results. Acta Oncol. 2006;45(7):961–5.CrossRef
15.
go back to reference Harada T, et al. Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy. Cancer. 2002;95(8):1720–7.CrossRef Harada T, et al. Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy. Cancer. 2002;95(8):1720–7.CrossRef
16.
go back to reference Reichner CA, et al. The placement of gold fiducials for CyberKnife stereotactic radiosurgery using a modified transbronchial needle aspiration technique. J Bronchology Interv Pulmonol. 2005;12(4):193–5. Reichner CA, et al. The placement of gold fiducials for CyberKnife stereotactic radiosurgery using a modified transbronchial needle aspiration technique. J Bronchology Interv Pulmonol. 2005;12(4):193–5.
17.
go back to reference Bhagat N, et al. Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol. 2010;33(6):1186–91.CrossRef Bhagat N, et al. Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol. 2010;33(6):1186–91.CrossRef
18.
go back to reference Kothary N, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol. 2009;20(2):235–9.CrossRef Kothary N, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol. 2009;20(2):235–9.CrossRef
19.
go back to reference Lischalk JW, et al. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol. 2016;5(4):379–87.CrossRef Lischalk JW, et al. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol. 2016;5(4):379–87.CrossRef
20.
go back to reference Harley DP, et al. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy. Ann Thorac Surg. 2010;89(2):368–74.CrossRef Harley DP, et al. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy. Ann Thorac Surg. 2010;89(2):368–74.CrossRef
21.
go back to reference Kular H, Mudambi L, Lazarus DR, Cornwell L, Zhu A, Casal RF. Safety and feasibility of prolonged bronchoscopy involving diagnosis of lung cancer, systematic nodal staging, and fiducial marker placement in a high-risk population. J Thorac Dis. 2016;8(6):1132.CrossRef Kular H, Mudambi L, Lazarus DR, Cornwell L, Zhu A, Casal RF. Safety and feasibility of prolonged bronchoscopy involving diagnosis of lung cancer, systematic nodal staging, and fiducial marker placement in a high-risk population. J Thorac Dis. 2016;8(6):1132.CrossRef
22.
go back to reference Kennedy, Andrew, et al. Stereotactic body radiation therapy in early stage non-small cell lung cancer: a brief primer for the multidisciplinary tumor board. 2018. Kennedy, Andrew, et al. Stereotactic body radiation therapy in early stage non-small cell lung cancer: a brief primer for the multidisciplinary tumor board. 2018.
23.
go back to reference Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e142S–65S.CrossRef Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e142S–65S.CrossRef
24.
go back to reference Gildea TR, et al. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med. 2006;174(9):982–9.CrossRef Gildea TR, et al. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med. 2006;174(9):982–9.CrossRef
25.
Metadata
Title
Improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB)
Authors
Hayley Stowe
Stella Ogake
Sunil Sharma
Suzanne Kelly
Morgan McDonald
Kayla Stanley
Paul Walker
Hyder Arastu
Carlos Anciano Granadillo
Mark Bowling
Andrew Ju
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2019
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-019-1306-0

Other articles of this Issue 1/2019

Radiation Oncology 1/2019 Go to the issue